Efficacy of phosphodiesterase type 5 inhibitors in univentricular congenital heart disease: the SV‐INHIBITION study design

AIMS: In univentricular hearts, selective lung vasodilators such as phosphodiesterase type 5 (PDE5) inhibitors would decrease pulmonary resistance and improve exercise tolerance. However, the level of evidence for the use of PDE5 inhibitors in patients with a single ventricle (SV) remains limited. W...

Descripción completa

Detalles Bibliográficos
Autores principales: Amedro, Pascal, Gavotto, Arthur, Abassi, Hamouda, Picot, Marie‐Christine, Matecki, Stefan, Malekzadeh‐Milani, Sophie, Levy, Marilyne, Ladouceur, Magalie, Ovaert, Caroline, Aldebert, Philippe, Thambo, Jean‐Benoit, Fraisse, Alain, Humbert, Marc, Cohen, Sarah, Baruteau, Alban‐Elouen, Karsenty, Clement, Bonnet, Damien, Hascoet, Sebastien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Study Designs
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160497/
https://www.ncbi.nlm.nih.gov/pubmed/32147955
http://dx.doi.org/10.1002/ehf2.12630

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160497/
https://www.ncbi.nlm.nih.gov/pubmed/32147955
http://dx.doi.org/10.1002/ehf2.12630

Ejemplares similares